Interleukin 1 stimulates platelet-activating factor production in cultured human endothelial cells

F. Bussolino, F. Breviario, C. Tetta, M. Aglietta, A. Mantovani, E. Dejana

Research output: Contribution to journalArticle

158 Citations (Scopus)

Abstract

Monocyte-derived interleukin 1 (IL-1) was found to be a potent inducer of platelet-activating factor (PAF) in cultured human vascular endothelial cells (HEC). The product was identified as PAF by its behavior in chromatographic systems, its recovery of biological activity, and its physico-chemical properties and susceptibility to lipases. The response of HEC to IL-1 was concentration-dependent, took more than 2 h to become apparent, and decreased after 18 h of incubation. Most of the PAF produced was cell-associated and only a small amount (about 25% of the total) was released in the culture medium. To study the mechanism of IL-1-induced HEC-PAF production we tested the activity of 1-O-alkyl-sn-glycero-3-phosphocholine:acetyl/coenzyme A acetyltransferase in HEC. Acetyltransferase activity measured in IL-1-stimulated HEC lysates showed a three to five times greater maximum velocity, but the same Michaelis constant, as untreated cells. The regulation of PAF generation in HEC by IL-1 may be an important aspect of the two-way interaction between immunocompetent cells and vascular tissue.

Original languageEnglish
Pages (from-to)2027-2033
Number of pages7
JournalJournal of Clinical Investigation
Volume77
Issue number6
Publication statusPublished - 1986

Fingerprint

Platelet Activating Factor
Interleukin-1
Endothelial Cells
Acetyl-CoA C-Acetyltransferase
Acetyltransferases
Lipase
Blood Vessels
Culture Media
Monocytes

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Interleukin 1 stimulates platelet-activating factor production in cultured human endothelial cells. / Bussolino, F.; Breviario, F.; Tetta, C.; Aglietta, M.; Mantovani, A.; Dejana, E.

In: Journal of Clinical Investigation, Vol. 77, No. 6, 1986, p. 2027-2033.

Research output: Contribution to journalArticle

@article{e15654fa512545b383b8b98e72ac4a6e,
title = "Interleukin 1 stimulates platelet-activating factor production in cultured human endothelial cells",
abstract = "Monocyte-derived interleukin 1 (IL-1) was found to be a potent inducer of platelet-activating factor (PAF) in cultured human vascular endothelial cells (HEC). The product was identified as PAF by its behavior in chromatographic systems, its recovery of biological activity, and its physico-chemical properties and susceptibility to lipases. The response of HEC to IL-1 was concentration-dependent, took more than 2 h to become apparent, and decreased after 18 h of incubation. Most of the PAF produced was cell-associated and only a small amount (about 25{\%} of the total) was released in the culture medium. To study the mechanism of IL-1-induced HEC-PAF production we tested the activity of 1-O-alkyl-sn-glycero-3-phosphocholine:acetyl/coenzyme A acetyltransferase in HEC. Acetyltransferase activity measured in IL-1-stimulated HEC lysates showed a three to five times greater maximum velocity, but the same Michaelis constant, as untreated cells. The regulation of PAF generation in HEC by IL-1 may be an important aspect of the two-way interaction between immunocompetent cells and vascular tissue.",
author = "F. Bussolino and F. Breviario and C. Tetta and M. Aglietta and A. Mantovani and E. Dejana",
year = "1986",
language = "English",
volume = "77",
pages = "2027--2033",
journal = "Journal of Clinical Investigation",
issn = "0021-9738",
publisher = "The American Society for Clinical Investigation",
number = "6",

}

TY - JOUR

T1 - Interleukin 1 stimulates platelet-activating factor production in cultured human endothelial cells

AU - Bussolino, F.

AU - Breviario, F.

AU - Tetta, C.

AU - Aglietta, M.

AU - Mantovani, A.

AU - Dejana, E.

PY - 1986

Y1 - 1986

N2 - Monocyte-derived interleukin 1 (IL-1) was found to be a potent inducer of platelet-activating factor (PAF) in cultured human vascular endothelial cells (HEC). The product was identified as PAF by its behavior in chromatographic systems, its recovery of biological activity, and its physico-chemical properties and susceptibility to lipases. The response of HEC to IL-1 was concentration-dependent, took more than 2 h to become apparent, and decreased after 18 h of incubation. Most of the PAF produced was cell-associated and only a small amount (about 25% of the total) was released in the culture medium. To study the mechanism of IL-1-induced HEC-PAF production we tested the activity of 1-O-alkyl-sn-glycero-3-phosphocholine:acetyl/coenzyme A acetyltransferase in HEC. Acetyltransferase activity measured in IL-1-stimulated HEC lysates showed a three to five times greater maximum velocity, but the same Michaelis constant, as untreated cells. The regulation of PAF generation in HEC by IL-1 may be an important aspect of the two-way interaction between immunocompetent cells and vascular tissue.

AB - Monocyte-derived interleukin 1 (IL-1) was found to be a potent inducer of platelet-activating factor (PAF) in cultured human vascular endothelial cells (HEC). The product was identified as PAF by its behavior in chromatographic systems, its recovery of biological activity, and its physico-chemical properties and susceptibility to lipases. The response of HEC to IL-1 was concentration-dependent, took more than 2 h to become apparent, and decreased after 18 h of incubation. Most of the PAF produced was cell-associated and only a small amount (about 25% of the total) was released in the culture medium. To study the mechanism of IL-1-induced HEC-PAF production we tested the activity of 1-O-alkyl-sn-glycero-3-phosphocholine:acetyl/coenzyme A acetyltransferase in HEC. Acetyltransferase activity measured in IL-1-stimulated HEC lysates showed a three to five times greater maximum velocity, but the same Michaelis constant, as untreated cells. The regulation of PAF generation in HEC by IL-1 may be an important aspect of the two-way interaction between immunocompetent cells and vascular tissue.

UR - http://www.scopus.com/inward/record.url?scp=0022479651&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0022479651&partnerID=8YFLogxK

M3 - Article

C2 - 2872233

AN - SCOPUS:0022479651

VL - 77

SP - 2027

EP - 2033

JO - Journal of Clinical Investigation

JF - Journal of Clinical Investigation

SN - 0021-9738

IS - 6

ER -